Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

135 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Genomic landscape of patients in a phase II study of zanubrutinib in ibrutinib- and/or acalabrutinib-intolerant patients with B-cell malignancies.
Xu L, Shadman M, Flinn IW, Levy MY, Porter R, Burke JM, Zafar SF, Cultrera JL, Misleh J, Kingsley EC, Yimer HA, Freeman B, Chaudhry A, Tumula PK, Gandhi MD, Crescenzo R, By K, Cohen A, Chen DY, Idoine A, Manda S, Sharman JP, Ramakrishnan V. Xu L, et al. Among authors: crescenzo r. Haematologica. 2024 Jul 1;109(7):2284-2289. doi: 10.3324/haematol.2023.283861. Haematologica. 2024. PMID: 38268449 Free PMC article. Clinical Trial. No abstract available.
Zanubrutinib in patients with previously treated B-cell malignancies intolerant of previous Bruton tyrosine kinase inhibitors in the USA: a phase 2, open-label, single-arm study.
Shadman M, Flinn IW, Levy MY, Porter RF, Burke JM, Zafar SF, Misleh J, Kingsley EC, Yimer HA, Freeman B, Rao SS, Chaudhry A, Tumula PK, Gandhi MD, Manda S, Chen DY, By K, Xu L, Liu Y, Crescenzo R, Idoine A, Zhang X, Cohen A, Huang J, Sharman JP. Shadman M, et al. Among authors: crescenzo r. Lancet Haematol. 2023 Jan;10(1):e35-e45. doi: 10.1016/S2352-3026(22)00320-9. Epub 2022 Nov 16. Lancet Haematol. 2023. PMID: 36400069 Clinical Trial.
[No title available]
[No authors listed] [No authors listed] PMID: 39112177
An Optimized NGS Workflow Defines Genetically Based Prognostic Categories for Patients with Uveal Melanoma.
Massimino M, Tirrò E, Stella S, Tomarchio C, Di Bella S, Vitale SR, Conti C, Puglisi M, Di Crescenzo RM, Varricchio S, Merolla F, Broggi G, Martorana F, Turdo A, Gaggianesi M, Manzella L, Russo A, Stassi G, Caltabiano R, Staibano S, Vigneri P. Massimino M, et al. Among authors: di crescenzo rm. Biomolecules. 2025 Jan 18;15(1):146. doi: 10.3390/biom15010146. Biomolecules. 2025. PMID: 39858540 Free PMC article.
Interventional cytopathologist perspective on the Milan System Classification: a study on 929 consecutive salivary gland fine-needle aspirations with a focus on challenging diagnostic categories.
Carillo AM, Sorice I, Salatiello M, Di Crescenzo RM, Pisapia P, Dell'Aversana Orabona G, Vigliar E, Staibano S, Troncone G, Bellevicine C. Carillo AM, et al. Among authors: di crescenzo rm. Pathologica. 2024 Dec;116(6):358-367. doi: 10.32074/1591-951X-N815. Pathologica. 2024. PMID: 39748721 Free article.
Biphenotypic Sinonasal Sarcoma with Orbital Invasion: A Literature Review and Modular System of Surgical Approaches.
Corvino S, de Divitiis O, Iuliano A, Russo F, Corazzelli G, Cohen D, Di Crescenzo RM, Palmiero C, Pontillo G, Staibano S, Strianese D, Elefante A, Mariniello G. Corvino S, et al. Among authors: di crescenzo rm. Cancers (Basel). 2024 Sep 27;16(19):3316. doi: 10.3390/cancers16193316. Cancers (Basel). 2024. PMID: 39409936 Free PMC article. Review.
135 results